Differential alterations of the CD4 and CD8 T cell subsets in HIV-infected patients on highly active antiretroviral therapy with low CD4 t cell restoration

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 5, 2012, Pages 1228-1237

  Méndez Lagares, Gema ^a   García Pergañeda, Antonio ^a   del Mar del Pozo Balado, María ^a   Genebat, Miguel ^a   Ruiz Mateos, Ezequiel ^a   García, María García ^a   Muñoz Fernández, María Ángeles ^b   Pacheco, Yolanda María ^a   Leal, Manuel ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

CD34; HsCRP; Immune reconstitution; Immunosenescence; Naive CD4 T cells; SCD14

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; CD34 ANTIGEN; INTERLEUKIN 7 RECEPTOR;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL AGING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EFFECTOR CELL; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; ANTI-HIV AGENTS; ANTIGENS, CD14; ANTIGENS, CD34; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; C-REACTIVE PROTEIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-7; T-LYMPHOCYTE SUBSETS;

EID: 84859618903     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr594     Document Type: Article

References (39)

1. Piketty C, Castiel P, Belec L et al. Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease. AIDS 1998; 12: 745-50.
2. Molina-Pinelo S, Vallejo A, Díaz L et al. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation. J Antimicrob Chemother 2009; 64: 579-88.
3. Pacheco YM, Jarrín I, Del Amo J et al. Risk factors, CD4 long-term evolution and mortality of HIV-infected patients who persistently maintain low CD4 counts, despite virological response to HAART. Curr HIV Res 2009; 7: 612-9.
4. Engsig FN, Gerstoft J, Kronborg G et al. Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study. BMC Infect Dis 2010; 10: 318.
5. Loutfy MR, Genebat M, Moore D et al. A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression. J Acquir Immune Defic Syndr 2010; 55: 451-9.
6. Abrams D, Lévy Y, Losso MH et al. Interleukin-2 therapy in patients with HIV infection. N Engl J Med 2009; 361: 1548-59.
7. Gazzola L, Tincati C, Bellistrì GM et al. The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options. Clin Infect Dis 2009; 48: 328-37.
8. Pitrak DL, Bolaños J, Hershow R et al. Discordant CD4 T lymphocyte responses to antiretroviral therapy for HIV infection are associated with ex-vivo rates of apoptosis. AIDS 2001; 15: 1317-9.
9. Hazenberg MD, Otto SA, Wit FW et al. Discordant responses during antiretroviral therapy: role of immune activation and T cell redistribution rather than true CD4 T cell loss. AIDS 2002; 16: 1287-9.
10. Fernandez S, Price P, McKinnon EJ et al. Low CD4+ T-cell counts in HIV patients receiving effective antiretroviral therapy are associated with CD4+ T-cell activation and senescence but not with lower effector memory T-cell function. Clin Immunol 2006; 120: 163-70.
11. Mavigner M, Delobel P, Cazabat M et al. HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy. PLoS ONE 2009; 4: e7658.
12. Delobel P, Nugeyre MT, Cazabat M et al. Naïve T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy. J Virol 2006; 80: 10229-36.
13. Marchetti G, Gori A, Casabianca A et al. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART. AIDS 2006; 20: 1727-36.
14. Marziali M, De Santis W, Carello R et al. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART. AIDS 2006; 20: 2033-41.
15. Marchetti G, Bellistrì GM, Borghi E et al. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS 2008; 22: 2035-8.
16. Massanella M, Negredo E, Pérez-Álvarez N et al. CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART. AIDS 2010; 24: 959-68.
17. Sandler NG, Wand H, Roque A et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 2011; 203: 780-90.
18. Lien E, Aukrust P, Sundan A et al. Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events. Blood 1998; 92: 2084-92.
19. Brenchley JM, Price DA, Schacker TWet al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12: 1365-71.
20. Ferrando-Martínez S, Ruiz-Mateos E, Hernández A et al. Age-related deregulation of naive T cell homeostasis in elderly humans. Age 2011; 33: 197-207.
21. García-Merino I, de Las Cuevas N, Jiménez JL et al. Pediatric HIV BioBank: a new role of the Spanish HIV BioBank in pediatric HIV research. AIDS Res Hum Retroviruses 2010; 26: 241-4.
22. Ferrando-Martinez S, Ruiz-Mateos E, Leal M. CD27 and CCR7 expression on naïve T cells, are both necessary? Immunol Lett 2010; 127: 157-8.
23. Erikstrup C, Kronborg G, Lohse N et al. T-cell dysfunction in HIV-1-infected patients with impaired recovery of CD4 cells despite suppression of viral replication. J Acquir Immune Defic Syndr 2010; 53: 303-10.
24. Blom B, Spits H. Development of human lymphoid cells. Ann Rev Immunol 2006; 24: 287-320.
25. Duda DG, Cohen KS, Scadden DT et al. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2007; 2: 805-10.
26. Galy A, Travis M, Cen D et al. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 1995; 3: 459-73.
27. Haddad R, Guimiot F, Six E et al. Dynamics of thymus-colonizing cells during human development. Immunity 2006; 24: 217-30.
28. Hunt PW, Brenchley J, Sinclair E et al. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 2008; 197: 126-33.
29. Jiang W, Lederman MM, Hunt P et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 2009; 199: 1177-85.
30. Ridker PM, Danielson E, Fonseca FA et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-207.
31. Ferrando-Martínez S, Franco JM, Ruiz-Mateos E et al. A reliable and simplified sj/β-TREC ratio quantification method for human thymic output measurement. J Immunol Methods 2010; 352: 111-7.
32. Mendez-Lagares G, Pozo-Balado MM, Genebat M et al. Severe immune dysregulation affects CD4+CD25hiFoxP3+ regulatory T-cells in HIV infected patients with low-level CD4 T-cell repopulation despite suppressive HAART. J Infect Dis (in press).
33. Marchetti G, Gazzola L, Trabattoni D et al. Skewed T-cell maturation and function in HIV-infected patients failing CD4+ recovery upon long-term virologically suppressive HAART. AIDS 2010; 24: 1455-60.
34. Pawelec G, Koch S, Gouttefangeas C et al. Immunorejuvenation in the elderly. Rejuvenation Res 2006; 9: 111-6.
35. Isgrò A, Leti W, De Santis W et al. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART. Clin Infect Dis 2008; 46: 1902-10.
36. Six EM, Bonhomme D, Monteiro M et al. A human postnatal lymphoid progenitor capable of circulating and seeding the thymus. J Exp Med 2007; 204: 3085-93.
37. Fry TJ, Mackall CL. Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol 2001; 22: 564-71.
38. Napolitano LA, Grant RM, Deeks SG et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001; 7: 73-9.
39. Ruiz-Mateos E, de la Rosa R, Franco JM et al. Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy. AIDS 2003; 17: 947-54.